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follow up. Further up-titration of beta blocker or earlier initiation of
ivabradine on discharge should be considered.
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Background: National guidelines for heart failure recommend
prescription of certain classes of drugs to improve prognosis in
patients admitted with acute decompensated heart failure (ADHF). It
has been noted during clinical follow up such patients are discharged
with different treatment regimes.
Objective: To determine the relationship between drug treatment
regimes in patients admitted to a tertiary referral centre with ADHF
and their medium term clinical outcomes post-discharge, defined as
90-day mortality and hospital readmissions.
Methods: 94 cases with a discharge diagnosis of ADHF were
recruited from October 2017 until August 2018. Cases were analyzed
retrospectively for their medications at discharge. Patients were
followed-up for 90 days via phone.
Results: Out of 94 patients, 8 patients died during admission.
86 patientswere being analysed for clinical outcomes. 22 (26%) patients
were discharged without a single type of guideline recommended
medication for heart failure (GRM). 33 (38%) patients were discharged
on one type, 22 (26%) patients discharged with two types and 10 (12%)
patients were discharged with three or more types of GRM. The main
reasons for not being discharged with all GRM were chronic kidney
disease, obstructive lung disease, bradycardia and hypotension. The
90 days mortality rate was higher in patients discharged with ≤1 class
of GRM drugs compared to patients with discharged on ≥2 classes of
GRM drugs. (14.5% vs 6.5%; OR 2.25; 95%CI 0.51, 9.96; p=0.28). The
90 days readmission rate for ADHF was also higher for patients
discharged with ≤1 class of GRM drugs (20.0% vs 12.9%; OR 1.55;
95%CI 0.539, 4.457; p=0.416). Overall, patientswith dischargedwith ≤1
class of GRMdrugs had also a higher 90-day event rate (27.3% vs 19.4%;
OR 1.78; 95%CI 0.797, 3.993; p=0.16).
Conclusions: Discharging ADHF patients with ≥2 class of GRM
drugs was associated with lower 90 days readmission rates and
mortality.
Even at a tertiary referral centre, every effort should be made to
ensure patients admitted with ADHF are discharged on GRM.
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Background: Mortality and readmission due to heart failure is
contributing to increase healthcare burden. NT-proBNP is known
for its role in diagnosis of heart failure. Higher Killip score was found
to be associated with more inpatient death among ADHF patients
in Sarawak General Hospital. There are limited data on usage of NT
proBNP and Killip score to prognosticate post discharge clinical
outcome.
Objective: We aim to explore association of admission NT-ProBNP
and Killip score with 90-day mortality and readmission outcome.
Materials & Methods: 68 patients with a primary diagnosis
of ADHF were recruited between December 2017 to October 2018
in Sarawak General Hospital. NT-proBNP samples were collected
within 24hours from diagnosis. Patients were prospectively follow
up for 90 days from discharge. ROC curve analysis was applied to
determine the cut-off value of NT-proBNP with optimal sensitivity
and specificity. Factors (Age, gender, hypertension, diabetes,
dyslipidemia, admission BP, heart rate and EF) were investigated
for their role in affecting the discriminative value of NT-proBNP. Chi-
square analysis was used to compare differences in outcomes
between patients with NT-proBNP readings N5055pg/ml and those
with higher Killip score.
Results: Patients recruited had a median age of 63+/-17years old
and 57% are male. 36(54%) patients had admission Killip score of
N2. 16 (28%) patients recorded cumulative event of death and
readmission in 90 days post discharge. The median value of NT-
proBNP recorded in the cohort was 4115 pg/ml. ROC analysis
identified NT-proBNP as a useful tool in determining 90-day clinical
outcome (AUC=0.694, p=0.024). At the level of 5055 pg/ml, NT-
proBNP had a sensitivity and specificity of 66% and 69%. Performance
of NT-proBNP significantly improved in subpopulation of patients
who are less than 65 years old, male gender and those with
admission systolic blood pressure N100mmHg respectively (AUC up
to 0.871, p= 0.004). A combination of Killip score N2 with NT-
proBNP N5055 pg/ml showed almost 5-fold increase in risk of
developing 90-day event (OR 4.5714, 95% CI 1.3-15.7, p=0.0158).
Conclusion: Objective assessment using NT-proBNP and clinical
parameter of Killip scoring during admission are potentially useful in
determining 90-day outcome in patients with ADHF.
doi:10.1016/j.ijcard.2019.11.016
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Background: The most prevalent non-ischemic cardiomyopathies
are hypertrophic (HCM) and idiopathic dilated cardiomyopathy
(DCM). There are no published data regarding these conditions for
the Malaysian population.
Objective: To describe the presenting features, clinical char-
acteristics, management and outcome of individuals diagnosed with
HCM and DCM.
Materials & Methods: Patients diagnosed at a tertiary medical
centre with HCM or DCM were recruited into the study. Primary DCM
and HCM were determined by strict echocardiographic criteria. For
DCM patients, ischaemic pathogenesis had to be excluded by coronary
imaging. Patients with disease due to endocrine, immunologic, drug
toxicity, persistent tachycardia and other causes were excluded.
Results: 118 patients were diagnosed with either HCM or DCM
(M: F = 1:87; mean age 55 years) over a 3-year period.
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